文献速递血液透析通路慢性静脉疾病

锁骨上覆膜支架重建血液透析患者复杂中心静脉闭塞

Novel Reconstruction of Complex Central Venous Occlusion Using Supraclavicular Stent Graft in Hemodialysis Patients.
PubMed 文献 · Ann Vasc Surg · 2020-12-26

本研究回顾性分析8例合并锁骨下静脉和/或头臂静脉闭塞的血液透析患者,采用锁骨上覆膜支架重建静脉流出道。技术成功率和通路功能均为100%,中位随访254.5天,一期通畅率87.5%,二期通畅率100%,仅1例需再干预。该技术可安全有效地建立或挽救上肢血管通路。

要点

  • 锁骨上覆膜支架可成功重建血液透析患者复杂中心静脉闭塞的静脉流出道。
  • 术后中位随访254.5天,一期通畅率87.5%,二期通畅率100%。
  • 该技术可用于建立新上肢通路或挽救濒临失效的通路。

核心结论

  • 锁骨上覆膜支架置入中心静脉可成功重建血液透析患者复杂中心静脉闭塞的静脉流出道。
  • 锁骨上外解剖路径可安全有效地用于建立新上肢血管通路或挽救濒临失效的通路。

研究设计与样本

  • 回顾性研究,2019年1月至2020年1月共行297例开放手术和血管腔内透析通路手术。
  • 8例(2.7%)存在锁骨下静脉和/或头臂静脉闭塞且通路失效或濒临失效的患者接受锁骨上覆膜支架置入,平均年龄52岁(范围32-70岁)。

主要发现

  • 技术成功率和通路功能均为100%。
  • 1例发生缺血性神经病变,行动脉流入道近端化后改善。
  • 已有瘘管术后次日即可用于透析,新移植物在2-4周内使用,手臂水肿在术后1周内消退。
  • 中位随访254.5天(范围24-408天),一期通畅率87.5%,二期通畅率100%,仅1例需再干预。
  • 术后超声显示锁骨上皮下颈隧道区域支架移植物通畅。

临床怎么用

  • 对于合并锁骨下静脉和/或头臂静脉闭塞的血液透析患者,可考虑采用锁骨上覆膜支架重建静脉流出道。
  • 该技术可用于建立新的上肢血管通路或挽救濒临失效的通路。

局限性

  • 回顾性研究,样本量小(8例),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subclavian vein and brachiocephalic vein occlusions are challenging problems in dialysis patients with ipsilateral upper extremity (UE) vascular access or in need of one. HeRO grafts (Hemodialysis Reliable Outflow, Merit Medical Systems, Inc, South Jordan, UT) have been used to manage such occlusions but patients with chronic hypotension treated with HeRO graft may have threatened patency. We describe an alternative technique using a supraclavicular stent graft to reconstruct the venous outflow, evaluate outcomes of this procedure, and discuss its role in complex hemodialysis patients. METHODS: From January 2019 to January 2020, we performed open surgical and endovascular dialysis access procedures in 297 patients. Eight patients (2.7%) with failing or failed access and subclavian and or brachiocephalic vein occlusion were treated with supraclavicular stent graft placement. Mean age was 52 years, ranging from 32 to 70. Five patients had failed access and were dialyzed using catheters (two femoral). Three patients with failing fistulas had severe arm edema. Two patients had recurrent HeRO graft thrombosis. We performed a retrospective review of these 8 patients and evaluated access patency and complications. RESULTS: Technical success and access function were 100% in all patients. One patient developed ischemic neuropathy and underwent proximalization of the arterial inflow with improvement. Already-existing fistulas were used for dialysis the day after the procedure and new grafts within 2-4 weeks. Arm edema resolved within one week after the procedure. Median follow-up was 254.5 days, range 24-408 days, with primary patency rate of 87.5% and secondary patency rate of 100%. Only one patient has required reintervention. Postoperative evaluation with ultrasound has revealed patent stent graft in the area of the subcutaneous cervical tunnel over the clavicle. CONCLUSIONS: Supraclavicular stent graft placement to a central vein can be used successfully to reconstruct venous outflow in hemodialysis patients with complex central vein occlusions. A supraclavicular extra-anatomic path can be used safely and effectively to place new UE vascular access or salvage threatened access in this challenging patient population.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Uceda PV, Feldtman RW, Ahn SS, et al. Novel Reconstruction of Complex Central Venous Occlusion Using Supraclavicular Stent Graft in Hemodialysis Patients. Ann Vasc Surg. 2020. PMID: 33373762. doi:10.1016/j.avsg.2020.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。